34635668|t|First delirium episode in Parkinson's disease and parkinsonism: incidence, predictors, and outcomes.
34635668|a|To define the incidence, predictors and prognosis of the first hospital delirium episode in Parkinson's disease (PD) and atypical parkinsonism (AP), we identified the first hospital episode of delirium after diagnosis in the Parkinsonism Incidence in North-East Scotland (PINE) study, a prospective community-based incidence cohort of parkinsonism, using chart-based criteria to define delirium. Of 296 patients (189=PD, 107=AP [dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, vascular parkinsonism]), 152 developed delirium (PD = 98, AP = 54). Incidence of first hospital delirium episode per 100 person years was 8.1 (95% confidence interval [CI] 6.6-9.9) in PD and 18.5 (95% CI 13.9-24.7) in AP. Independent predictors of delirium were atypical parkinsonism (Hazard ratio [HR] vs PD = 2.83 [95% CI 1.60-5.03], age in PD but not in AP (HR for 10-year increase 2.29 [95% CI 1.74-3.02]), baseline MMSE (HR = 0.94 [95% CI 0.89-0.99]), APOE epsilon4 in PD (HR 2.16 [95% CI 1.15-4.08]), and MAPT H1/H1 in PD (HR 2.08 [95% CI 1.08-4.00]). Hazards of dementia and death after delirium vs before delirium were increased (dementia: HR = 6.93 [95% CI 4.18-11.48] in parkinsonism; death: HR = 3.76 [95% CI 2.65-5.35] in PD, 1.59 [95% CI 1.04-2.42] in AP). Delirium is a common non-motor feature of PD and AP and is associated with increased hazards of dementia and mortality. Whether interventions for early identification and treatment improve outcomes requires investigation.
34635668	6	14	delirium	Disease	MESH:D003693
34635668	26	45	Parkinson's disease	Disease	MESH:D010300
34635668	50	62	parkinsonism	Disease	MESH:D010302
34635668	173	181	delirium	Disease	MESH:D003693
34635668	193	212	Parkinson's disease	Disease	MESH:D010300
34635668	214	216	PD	Disease	MESH:D010300
34635668	222	243	atypical parkinsonism	Disease	MESH:C566823
34635668	245	247	AP	Disease	MESH:C566823
34635668	294	302	delirium	Disease	MESH:D003693
34635668	326	338	Parkinsonism	Disease	MESH:D010302
34635668	436	448	parkinsonism	Disease	MESH:D010302
34635668	487	495	delirium	Disease	MESH:D003693
34635668	504	512	patients	Species	9606
34635668	518	520	PD	Disease	MESH:D010300
34635668	526	528	AP	Disease	MESH:C566823
34635668	530	555	dementia with Lewy bodies	Disease	MESH:D020961
34635668	557	587	progressive supranuclear palsy	Disease	MESH:D013494
34635668	589	612	multiple system atrophy	Disease	MESH:D019578
34635668	614	635	vascular parkinsonism	Disease	MESH:D010302
34635668	653	661	delirium	Disease	MESH:D003693
34635668	663	665	PD	Disease	MESH:D010300
34635668	672	674	AP	Disease	MESH:C566823
34635668	710	718	delirium	Disease	MESH:D003693
34635668	798	800	PD	Disease	MESH:D010300
34635668	832	834	AP	Disease	MESH:C566823
34635668	862	870	delirium	Disease	MESH:D003693
34635668	876	897	atypical parkinsonism	Disease	MESH:C566823
34635668	920	922	PD	Disease	MESH:D010300
34635668	957	959	PD	Disease	MESH:D010300
34635668	971	973	AP	Disease	MESH:C566823
34635668	1071	1075	APOE	Gene	348
34635668	1088	1090	PD	Disease	MESH:D010300
34635668	1125	1129	MAPT	Gene	4137
34635668	1139	1141	PD	Disease	MESH:D010300
34635668	1183	1191	dementia	Disease	MESH:D003704
34635668	1196	1201	death	Disease	MESH:D003643
34635668	1208	1216	delirium	Disease	MESH:D003693
34635668	1227	1235	delirium	Disease	MESH:D003693
34635668	1252	1260	dementia	Disease	MESH:D003704
34635668	1295	1307	parkinsonism	Disease	MESH:D010302
34635668	1309	1314	death	Disease	MESH:D003643
34635668	1348	1350	PD	Disease	MESH:D010300
34635668	1379	1381	AP	Disease	MESH:C566823
34635668	1384	1392	Delirium	Disease	MESH:D003693
34635668	1426	1428	PD	Disease	MESH:D010300
34635668	1433	1435	AP	Disease	MESH:C566823
34635668	1480	1488	dementia	Disease	MESH:D003704
34635668	Association	MESH:D010300	348

